Feasibility and potential clinical benefit of dose de-escalation in stereotactic ablative radiotherapy for lung cancer lesions with ground glass opacities
Introduction: Treatment of neoplasic lung nodules with ground glass opacities (GGO) faces two primary challenges.First, the standard practice of treating GGOs as solid nodules, which effectively controls the tumor locally, but might increase associated toxicities.The second is the potential for dose calculation errors related to increased heterogen